Compare PROF & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | PCYO |
|---|---|---|
| Founded | N/A | 1976 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.8M | 264.1M |
| IPO Year | 2017 | 1995 |
| Metric | PROF | PCYO |
|---|---|---|
| Price | $5.60 | $10.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $11.14 | N/A |
| AVG Volume (30 Days) | ★ 264.5K | 68.5K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | 12.50 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $16,098,000.00 | $1,227,787.00 |
| Revenue This Year | $71.10 | N/A |
| Revenue Next Year | $58.54 | N/A |
| P/E Ratio | ★ N/A | $29.89 |
| Revenue Growth | 50.73 | ★ 171.54 |
| 52 Week Low | $4.91 | $9.71 |
| 52 Week High | $8.95 | $12.44 |
| Indicator | PROF | PCYO |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 41.97 |
| Support Level | $4.97 | $10.67 |
| Resistance Level | $7.19 | $11.03 |
| Average True Range (ATR) | 0.44 | 0.20 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 3.23 | 31.48 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.